What is Medtronic's operating cash flow?

Latest reported operating cash flow for Medtronic (MDT) is $2.57B as of the trailing twelve months (TTM) ending April 24, 2026.

How has Medtronic operating cash flow changed year-over-year?

Medtronic (MDT) operating cash flow changed +4.1% year-over-year on the latest annual filing.

What is the long-term growth rate of Medtronic operating cash flow?

Medtronic (MDT) operating cash flow compound annual growth rate is +3.3% over the most recent 5 years available.

When did Medtronic operating cash flow hit its highest annual value?

Medtronic operating cash flow reached its highest annual value of $7.35B in 2022.

What was Medtronic operating cash flow in 2025?

Medtronic (MDT) operating cash flow in 2025 was $7.04B.

What was Medtronic operating cash flow in 2026?

Medtronic (MDT) operating cash flow in 2026 was $7.33B.

Medtronic (MDT) Operating Cash Flow

Latest period

$2.57B

YoY change

+4.1%

5Y CAGR

+3.3%

Peak year (2022)

$7.35B

Operating Cash Flow history chart for Medtronic (MDT) from 1990 to 2026

Latest: $7.33B

Operating Cash Flow growth chart for Medtronic (MDT) from 1990 to 2026

Latest: +4.1%

Operating Cash Flow history table for Medtronic (MDT) from 1990 to 2026


2026	$7.33B	+4.1%	+$286.00M	Apr 24, 2026	Jun 3, 2026
2025	$7.04B	+3.8%	+$257.00M	Apr 30, 2025	Jun 20, 2025
2024	$6.79B	+12.4%	+$748.00M	Apr 30, 2024	Jun 20, 2024
2023	$6.04B	-17.8%	−$1.31B	Apr 30, 2023	Jun 22, 2023
2022	$7.35B	+17.7%	+$1.11B	Apr 30, 2022	Jun 23, 2022
2021	$6.24B	-13.7%	−$994.00M	Apr 30, 2021	Jun 25, 2021
2020	$7.23B	+3.2%	+$227.00M	Apr 30, 2020	Jun 19, 2020
2019	$7.01B	+49.6%	+$2.32B	Apr 30, 2019	Jun 21, 2019
2018	$4.68B	-31.9%	−$2.20B	Apr 30, 2018	Jun 22, 2018
2017	$6.88B	+31.9%	+$1.66B	Apr 30, 2017	Jun 27, 2017
2016	$5.22B	+6.4%	+$316.00M	Apr 30, 2016	Jun 28, 2016
2015	$4.90B	-1.1%	−$57.00M	Apr 30, 2015	Jun 23, 2015
2014	$4.96B	+1.6%	+$76.00M	Apr 30, 2014	Apr 30, 2014
2013	$4.88B	+11.5%	+$502.00M	Apr 30, 2013	Apr 30, 2013
2012	$4.38B	+17.1%	+$640.00M	Apr 30, 2012	Apr 30, 2012
2011	$3.74B	-9.4%	−$390.00M	Apr 30, 2011	Apr 30, 2011
2010	$4.13B	+6.5%	+$253.00M	Apr 30, 2010	Apr 30, 2010
2009	$3.88B	+11.1%	+$389.00M	Apr 30, 2009	Apr 30, 2009
2008	$3.49B	+17.1%	+$510.00M	Apr 30, 2008	Apr 30, 2008
2007	$2.98B	+35.0%	+$771.60M	Apr 30, 2007	Apr 30, 2007
2006	$2.21B	-21.7%	−$612.00M	Apr 30, 2006	Apr 30, 2006
2005	$2.82B	-0.9%	−$26.40M	Apr 30, 2005	Apr 30, 2005
2004	$2.85B	+36.9%	+$767.60M	Apr 30, 2004	Apr 30, 2004
2003	$2.08B	+30.7%	+$488.00M	Apr 30, 2003	Apr 30, 2003
2002	$1.59B	-13.2%	−$241.30M	Apr 30, 2002	Apr 30, 2002
2001	$1.83B	+75.8%	+$789.50M	Apr 30, 2001	Apr 30, 2001
2000	$1.04B	+128.9%	+$586.70M	Apr 30, 2000	Apr 30, 2000
1999	$455.30M	-22.8%	−$134.80M	Apr 30, 1999	Apr 30, 1999
1998	$590.10M	+27.3%	+$126.50M	Apr 30, 1998	Apr 30, 1998
1997	$463.60M	-7.4%	−$36.90M	Apr 30, 1997	Apr 30, 1997
1996	$500.50M	+29.3%	+$113.30M	Apr 30, 1996	Apr 30, 1996
1995	$387.20M	+8.5%	+$30.30M	Apr 30, 1995	Apr 30, 1995
1994	$356.90M	+22.4%	+$65.40M	Apr 30, 1994	Apr 30, 1994
1993	$291.50M	+92.5%	+$140.10M	Apr 30, 1993	Apr 30, 1993
1992	$151.40M	+19.6%	+$24.80M	Apr 30, 1992	Apr 30, 1992
1991	$126.60M	+18.5%	+$19.80M	Apr 30, 1991	Apr 30, 1991
1990	$106.80M	—	—	Apr 30, 1990	Apr 30, 1990

2026$7.33B+4.1%
2025$7.04B+3.8%
2024$6.79B+12.4%
2023$6.04B-17.8%
2022$7.35B+17.7%
2021$6.24B-13.7%
2020$7.23B+3.2%
2019$7.01B+49.6%
2018$4.68B-31.9%
2017$6.88B+31.9%
2016$5.22B+6.4%
2015$4.90B-1.1%
2014$4.96B+1.6%
2013$4.88B+11.5%
2012$4.38B+17.1%
2011$3.74B-9.4%
2010$4.13B+6.5%
2009$3.88B+11.1%
2008$3.49B+17.1%
2007$2.98B+35.0%
2006$2.21B-21.7%
2005$2.82B-0.9%
2004$2.85B+36.9%
2003$2.08B+30.7%
2002$1.59B-13.2%
2001$1.83B+75.8%
2000$1.04B+128.9%
1999$455.30M-22.8%
1998$590.10M+27.3%
1997$463.60M-7.4%
1996$500.50M+29.3%
1995$387.20M+8.5%
1994$356.90M+22.4%
1993$291.50M+92.5%
1992$151.40M+19.6%
1991$126.60M+18.5%
1990$106.80M—

Operating Cash Flow values are taken from Medtronic's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Operating Cash Flow at Medtronic (MDT)

Operating Cash Flow for Medtronic (MDT): headline value $2.57B · YoY +4.1%. Annual and quarterly series, chart, and tables are below.

Headline figure above is from the reporting period ending April 24, 2026 (reported June 3, 2026). Chart and table below cover the full reported history back to 1990.

The 2026 reading of Medtronic (MDT) operating cash flow is $7.33B – edged up 4.1% year-over-year.

Medtronic operating cash flow has grown for 3 consecutive years, with a +3.3% compound annual growth rate over 2021–2026 (5 years).

The record annual operating cash flow stands at $7.35B, reached in 2022; the historical low of $106.80M was recorded in 1990.

Medtronic Operating Cash Flow by Year

Medtronic Operating Cash Flow 2026: $7.33B

2026's operating cash flow for Medtronic came in at $7.33B, edged up 4.1% from 2025.

Medtronic Operating Cash Flow 2025: $7.04B

Medtronic posted operating cash flow of $7.04B in 2025, edged up 3.8% from 2024.

Medtronic Operating Cash Flow 2024: $6.79B

In 2024, Medtronic reported operating cash flow of $6.79B, grew 12.4% from 2023.

Medtronic Operating Cash Flow 2023: $6.04B

Medtronic operating cash flow in 2023 was $6.04B, declined 17.8% below 2022.

Medtronic Operating Cash Flow 2022: $7.35B

Medtronic operating cash flow in 2022 was $7.35B.

See more financial history for Medtronic (MDT).

Sector peers by Operating Cash Flow

Healthcare peers of Medtronic (MDT), ranked by their latest operating cash flow


Johnson & Johnson (JNJ)	$24.53B
UnitedHealth Group (UNH)	$19.70B
AbbVie (ABBV)	$19.03B
Novo Nordisk (NVO)	$18.56B
Eli Lilly (LLY)	$16.81B
Merck & Co. (MRK)	$16.47B
AstraZeneca (AZN)	$14.57B
Amgen (AMGN)	$9.96B

Frequently asked questions

Medtronic (MDT) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation